The FDA has released the following: Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, ...
The recall is over the presence of nitrosamine being above the established Acceptable Daily Intake level by Pfizer. According to the company announcement, long-term ingestion of nitrosamine may be ...
PRINCETON, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced it has launched a patient support program called TEAMTyrvaya™ where eligible1 patients can ...
The FDA has released the following: Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, ...
Pfizer has announced a recall of varenicline, the anti-smoking drug sold under the brand name Chantix, for the second time in two weeks. Both recalls, the latest on Friday, concern the presence of ...
For the third time this summer, Pfizer issued a recall of popular anti-smoking medication Chantix that might have too much of the carcinogen N-nitroso-varenicline. That’s too much for Pfizer, not the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback